Anti-MART-1 F5 Lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-MART-1 F5 Lymphocytes, covering 2013-03-19 to 2013-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients [Phase 2]